% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Aziz:282970,
author = {Aziz, N. Ahmad and Claassen, Daniel and Petersén, Åsa and
Weydt, Patrick and Network, European Huntington's Disease
and Group, Huntington Study},
title = {β-{B}locker effects in huntington's disease: {A} caution
on clinical interpretation.},
journal = {Journal of Huntington's disease},
volume = {Advance online publication},
issn = {1879-6397},
address = {Amsterdam},
publisher = {IOS Press},
reportid = {DZNE-2025-01422},
pages = {-},
year = {2025},
abstract = {A recent retrospective analysis of Enroll HD data
suggesting β-blockers slow Huntington's disease progression
has triggered patient demand but requires caution. The
findings rely solely on small observational subsets and are
vulnerable to bias and confounding. A prior
Mendelian-randomization study found no causal link between
β-blockers and HD onset; instead, genetically higher blood
pressure was associated with later onset, raising concern
that β-blockers' BP-lowering effects could be harmful. HD
patients also have lower hypertension rates, and β-blockers
carry risks such as depression and bradycardia. Given their
heterogeneous mechanisms, rigorous experimental and clinical
trials are needed before any clinical recommendations.},
keywords = {bioethics (Other) / biostatistics (Other) / clinical care
(Other) / clinical trials (Other) / ethics (Other)},
cin = {Clinical Research (Bonn) / AG Aziz},
ddc = {610},
cid = {I:(DE-2719)1011001 / I:(DE-2719)5000071},
pnm = {354 - Disease Prevention and Healthy Aging (POF4-354) / 353
- Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-354 / G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41395805},
doi = {10.1177/18796397251401745},
url = {https://pub.dzne.de/record/282970},
}